Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection | Science
Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines: Cell Systems
ZHIMIN WANG | Institut Curie
Advances and gaps in SARS-CoV-2 infection models | PLOS Pathogens
SARS-CoV-2 Antiviral Therapy | Clinical Microbiology Reviews
Medicina | Free Full-Text | Validation of Cognitive Rehabilitation as a Balance Rehabilitation Strategy in Patients with Parkinson's Disease: Study Protocol for a Randomized Controlled Trial
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection | Science Immunology
Muscle Toxicity of Drugs: When Drugs Turn Physiology into Pathophysiology | Physiological Reviews
Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus | Circulation
Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy | Physiological Reviews
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial - The Lancet Neurology
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants | mBio
A Highly Potent SARS-CoV-2 Blocking Lectin Protein | ACS Infectious Diseases
Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect
Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances
Publications | Dhanasekaran Lab | Stanford Medicine
Publications | Dhanasekaran Lab | Stanford Medicine
